Lv3
400 积分 2026-01-30 加入
Joint Clinical Assessments — A New Chapter in European Pharmaceutical Policy
16天前
已完结
Age at Diagnosis and Clinical and Genetic Profiles Among Adults With Attention-Deficit/Hyperactivity Disorder
28天前
已关闭
Non-approval in the sunlight: FDA's CRL disclosures, the limits of confidentiality, and lessons from the EMA
1个月前
已关闭
The African Medicines Agency: historical perspective of its origins, evolution, institutional structure and future prospects
2个月前
已完结
Patent Portfolios Protecting 10 Top-Selling Prescription Drugs
2个月前
已完结
The public health impact of the Medicines Patent Pool increases with the fragmentation of intellectual property rights
3个月前
已完结
Trends in the landscape of clinical trials of innovative drugs in China since 2015
4个月前
已完结
Regulation of Real‐World Evidence in Rare Diseases in the MENA Region: A Review of Current Guidelines Compared to Global Frameworks
4个月前
已完结
Post‐Approval Pediatric Use of Drugs Granted Waivers from Pediatric Testing
4个月前
已完结
Delisting of Pharmaceutical Patents Challenged by the Federal Trade Commission
5个月前
已完结
皖公网安备34019202002308
